Safety evaluation of collagenase from Streptomyces violaceoruber

A safety assessment was conducted for microbial collagenase (COL) enzyme expressed in Streptomyces violaceoruber. The acute oral toxicity of COL was examined in Sprague-Dawley rats and the LD50 of COL via single oral administration to rats was higher than 2000 mg/kg body weight. A 13-week oral gavage study of COL showed no adverse effects due to the enzyme up to a dose of 234.9 mg total organic solids (TOS)/kg body weight per day (NOAEL). A bacterial reverse mutation WA showed no mutagenic activity at the highest dose (4698 mu g TOS per plate). In the mouse lymphoma TK assay, a positive result was observed at the highest dose of 4698 mu g TOS/mL although it had low reproducibility. To confirm the chromosome aberration potential, an in vivo micronucleus WA was conducted that demonstrated the lack of mutagenic potential on the bone marrow of rats at doses up to 1879 mg TOS/kg body weight per day. The results of the genotoxicity studies and acute and subchronic rat studies support the safe use in food production of collagenase produced from S. violaceoruber.